Protocol Ledger

NCT07392450 · Phase II · RECRUITING

A Study of TAK-755 in Adults With Acute Ischemic Stroke

Interventional Phase II clinical trial protocol NCT07392450 sponsored by Takeda in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-05-17 Enrollment: 222 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07392450
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)222 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07392450
Protocol FieldVerified Registry Value
NCT IdentifierNCT07392450
Consolidated Lead SponsorTakeda
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment222 participants (ESTIMATED)
Registered Start Date2026-05-17
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Takeda across sibling Meru public-data platforms.

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI